OrbiMed Launches $307M Second Israel Fund

Healthcare investment firm OrbiMed has announced the closing of its second Israel-focused venture capital fund, OrbiMed Israel Partners II, LP, with approximately $307 million in capital commitments. Investors in the fund include several of the world’s largest healthcare companies, in addition to dozens of institutional investors and family offices. Like its predecessor fund, OrbiMed Israel Partners II will target all stages and sectors of the healthcare industry, with a focus on biopharmaceuticals, digital health, medical devices, and diagnostics companies in Israel. The fund is targeting to invest in approximately 20 portfolio companies. OrbiMed’s Israel office, located in Herzliya, was opened in 2010, and is led by Dr. Nissim Darvish, Erez Chimovits, and Anat Naschitz. OrbiMed has offices in New York, San Francisco, Mumbai, and Shanghai.